Source:http://linkedlifedata.com/resource/pubmed/id/14744278
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-1-27
|
pubmed:abstractText |
Despite existing strategies for the treatment of vasospasm after aneurysmal subarachnoid hemorrhage, vasospasm remains a persistent contributor to death and disability. The intracisternal application of thrombolytic agents to dissolve subarachnoid clot has been advocated. The goal of this analysis was to assess the currently available evidence regarding the effectiveness of this treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0148-396X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
326-34; discussion 334-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14744278-Cisterna Magna,
pubmed-meshheading:14744278-Controlled Clinical Trials as Topic,
pubmed-meshheading:14744278-Fibrinolytic Agents,
pubmed-meshheading:14744278-Humans,
pubmed-meshheading:14744278-Subarachnoid Hemorrhage,
pubmed-meshheading:14744278-Thrombolytic Therapy,
pubmed-meshheading:14744278-Treatment Outcome,
pubmed-meshheading:14744278-Vasospasm, Intracranial
|
pubmed:year |
2004
|
pubmed:articleTitle |
Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis.
|
pubmed:affiliation |
Neurosurgical Service, Massachusetts General Hospital, Harvard Medical School, Fruit Street, Boston, MA 02114, USA.
|
pubmed:publicationType |
Journal Article,
Meta-Analysis
|